FDA approves J&J drug for advanced multiple myeloma
November 16, 2015 at 13:54 PM EST
Nov 16 (Reuters) - U.S. regulators have approved an experimental treatment from Johnson & Johnson that may offer hope to multiple myeloma patients who have run out of other options against the blood cancer.
